Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
Type of Medium
Language
Region
Library
Years
Person/Organisation
  • 1
    Online Resource
    Online Resource
    London, England :Academic Press,
    UID:
    almahu_9949858129602882
    Format: 1 online resource (184 pages)
    Edition: First edition.
    ISBN: 9780443302886 , 044330288X
    Note: Intro -- Active Peptides for Skin Care -- Copyright -- Contents -- Contributors -- Chapter One: Skin -- 1. Skin anatomy and physiology -- 1.1. Skin anatomy -- 1.1.1. Epidermis -- Stratum corneum -- Stratum lucidum -- Stratum granulosum -- Stratum spinosum -- Stratum basale -- Basement membrane -- 1.1.2. Dermis -- Dermal cells -- Hair fibers -- Sebaceous glands -- Sweat glands -- Blood vessels -- 1.1.3. Subcutaneous layer -- 1.2. Skin barrier -- 2. Aging skin -- 2.1. Internal factors -- 2.1.1. Genetics -- 2.1.2. Free oxygen radicals -- 2.1.3. Nonenzymatic glycosylation (NEG) -- 2.2. External factors -- 2.2.1. Exposure to sunlight -- 2.2.2. Environmental pollution -- 2.2.3. Unhealthy lifestyle -- 3. Skin care and beauty -- 3.1. Skincare -- 3.1.1. Healthy lifestyle -- 3.1.2. Emotion management -- 3.1.3. Skin hygiene -- 3.1.4. Prevention and precaution -- 3.2. Cosmetology -- 3.2.1. Esthetic injection -- 3.2.2. Chemexfoliation -- 3.2.3. Laser procedure -- 3.2.4. Skincare products -- References -- Chapter Two: Active peptides -- 1. The history and research of active peptides -- 2. Overview of peptides -- 2.1. The concept of ``peptides´´ -- 2.2. Difference among peptide, protein, and amino acid -- 3. Application of peptides -- 3.1. Pharmaceutical peptides -- 3.2. Cosmetic peptides -- 3.3. Food peptides -- 4. Types of peptides -- 5. Peptide synthesis -- 5.1. Chemical synthesis -- 5.1.1. Liquid-phase synthesis -- 5.1.2. Solid-phase peptide synthesis -- 5.2. Peptide purification -- 5.3. Genetic recombination of peptide synthesis -- 5.4. Protein hydrolysis -- 5.5. Acidolysis -- References -- Chapter Three: Transdermal therapeutic systems of peptides -- 1. Overview of transdermal therapeutic systems (TTS) -- 2. How transdermal therapeutic systems work -- 2.1. Routes of transdermal therapeutic systems -- 2.2. How transdermal therapeutic systems work. , 2.2.1. Transdermal diffusion process -- 2.2.2. The principle of osmotic pressure -- 2.2.3. Hydration theory -- 2.2.4. ``Like dissolves like´´ theory -- 2.2.5. Structural change theory -- 3. Transdermal drug delivery techniques -- 3.1. Physical approaches to transdermal drug delivery -- 3.1.1. Microporation -- 3.1.2. Iontophoresis -- 3.1.3. Electroporation -- 3.1.4. Sonophoresis -- 3.1.5. Laser technology -- 3.1.6. Spray-on transdermal spray-on systems -- 3.1.7. Other physical techniques -- 3.2. Pharmaceutical methods for transdermal drug delivery -- 3.2.1. Penetration enhancers -- 3.2.2. Liposomes -- 3.2.3. Nanoparticles -- 3.2.4. Microemulsion -- 3.2.5. Microencapsulation -- 4. Transdermal drug delivery of cosmetic peptides -- 4.1. Properties of cosmetic peptides -- 4.2. Research of transdermal absorption of cosmetic peptides -- 4.3. What are transdermal mediator peptides -- 4.4. Future transdermal drug delivery of cosmetic peptides -- References -- Chapter Four: Quality research of peptides -- 1. Analysis of peptide structure -- 1.1. Amino acid analysis -- 1.1.1. Postcolumn derivatization -- 1.1.2. Precolumn derivatization -- Phenyl isothiocyanate (PITC) derivatization -- O-Phthalaldehyde (OPA) derivatization -- 6-Aminoquinolinyl-N-hydroxysuccinimidyl carbamate (AQC) derivatization -- Dansyl chloride (Dansyl-Cl) derivatization -- 9-Fluorenylmethyl chloroformate (FMOC-Cl) derivatization -- 1.2. Sequence analysis -- 1.3. Mass spectrometry -- 1.3.1. Fast atom mass spectrometry (FAB-MS) -- 1.3.2. Electrospray ionization mass spectrometry (ESI-MS) -- 1.4. Peptide spectrum analysis -- 2. Purity analysis and content determination -- 2.1. Purity analysis of peptides -- 2.2. Content determination of peptides -- 3. Research on peptide impurities -- 3.1. Impurities from raw materials -- 3.2. Impurities from the process of synthesis. , 3.2.1. Isometric peptide impurities -- 3.2.2. Defective peptide impurities -- 3.2.3. Disjuncted peptide impurities -- 3.2.4. Protected peptide impurities -- 3.3. Degradation of impurities -- 3.3.1. Impurities from hydrolysis -- 3.3.2. Impurities from oxidation -- References -- Chapter Five: Whitening and spot-correcting peptides -- 1. Overview -- 2. Introduction of whitening and spot-correcting peptides -- 2.1. Nonapeptide-1 -- 2.1.1. INCI name -- 2.1.2. Biological functions -- 2.1.3. Mechanism of action -- 2.1.4. Effects -- 2.2. Glutathione -- 2.2.1. INCI name -- 2.2.2. Biological functions -- Scavenging free radicals -- Inhibiting lipid peroxidation of cell membranes -- Tyrosinase inhibition -- 2.2.3. Mechanism of action -- 2.2.4. Effects -- 2.3. Carnosine -- 2.3.1. INCI name -- 2.3.2. Biological functions -- Antioxidation and anti-ROS -- Antiaging -- Protein carbonylation inhibition -- 2.3.3. Mechanism of action -- 2.3.4. Effects -- 2.4. Hexapeptide-2 -- 2.4.1. INCI name -- 2.4.2. Mechanism of action -- 2.4.3. Effects -- 3. Whitening product application -- 3.1. Formulation -- 3.1.1. Formulation example -- 3.2. Processing -- 3.3. Whitening active ingredients -- 3.4. Whitening results -- References -- Chapter Six: Antiaging and repairing peptides -- 1. Overview -- 2. Antiaging pathways -- 3. Introduction of antiaging peptides -- 3.1. Carnosine -- 3.1.1. INCI name -- 3.1.2. Biological functions -- 3.1.3. Mechanism of action -- 3.1.4. Effects -- 3.2. Palmitoyl pentapeptide-4 -- 3.2.1. INCI name -- 3.2.2. Biological functions -- 3.2.3. Mechanism of action -- 3.2.4. Effects -- 3.3. Palmitoyl tripeptide-1 -- 3.3.1. INCI name -- 3.3.2. Biological functions -- 3.3.3. Mechanism of action -- 3.3.4. Effects -- 3.4. Palmitoyl tetrapeptide-7 -- 3.4.1. INCI name -- 3.4.2. Biological functions -- 3.4.3. Mechanism of action -- 3.4.4. Effects. , 3.5. Copper tripeptide-1 -- 3.5.1. INCI name -- 3.5.2. Biological functions and mechanism of action -- 3.5.3. Effects -- 3.6. Palmitoyl tripeptide-5 -- 3.6.1. INCI name -- 3.6.2. Biological functions -- 3.6.3. Mechanism of action -- 3.6.4. Effects -- 3.7. Palmitoyl hexapeptide-12 -- 3.7.1. INCI name -- 3.7.2. Biological functions [3] -- 3.7.3. Mechanism of action -- 3.7.4. Effects -- 3.8. Hexapeptide-9 -- 3.8.1. INCI name -- 3.8.2. Biological functions -- 3.8.3. Mechanism of action -- 3.8.4. Effects -- 3.9. Hexapeptide-11 -- 3.9.1. INCI name -- 3.9.2. Biological functions -- 3.9.3. Mechanism of action -- 3.9.4. Effects -- 4. Product application -- 4.1. Formulation -- 4.1.1. Product/formulation case study -- 4.2. Processing -- 4.3. Core active ingredients -- 4.4. Efficacy test -- References -- Chapter Seven: Antisensitive and soothing peptides -- 1. Overview -- 1.1. Sensitive skin -- 1.2. Causes of sensitive skin -- 1.2.1. Weakened skin barrier -- 1.2.2. Increased cutaneous nerve conduction -- 1.2.3. Inflammatory response -- 2. Introduction to antisensitive and soothing peptides -- 2.1. Palmitoyl tripeptide-8 -- 2.1.1. INCI name -- 2.1.2. Biological functions -- 2.1.3. Mechanism of action -- 2.1.4. Effects -- 2.2. Acetyl dipeptide-1 cetyl ester -- 2.2.1. INCI name -- 2.2.2. Biological function -- 2.2.3. Mechanism of action -- 2.2.4. Effects -- 2.3. Acetyl hexapeptide-95 amide -- 2.3.1. INCI name -- 2.3.2. Biological function -- 2.3.3. Mechanism of action -- 2.3.4. Effects -- 3. Product application -- 3.1. Product/formulation case study -- 3.1.1. Formulation -- 3.1.2. Processing -- 3.1.3. Core active ingredients -- References -- Chapter Eight: Antihair loss peptides -- 1. Overview -- 2. Introduction of antihair loss peptides -- 2.1. Biotinoyl tripeptide-1 -- 2.1.1. INCI name -- 2.1.2. Biological functions -- 2.1.3. Mechanism of action -- 2.1.4. Effects. , 2.2. Myristoyl pentapeptide-17 -- 2.2.1. INCI name -- 2.2.2. Biological functions -- 2.2.3. Mechanism of action -- 2.2.4. Effects -- 2.3. Acetyl tetrapeptide-3 -- 2.3.1. INCI name -- 2.3.2. Biological functions -- 2.3.3. Mechanism of action -- 2.3.4. Effects -- 2.4. Oligopeptide-1 -- 2.4.1. INCI name -- 2.4.2. Biological functions -- 2.4.3. Mechanism of action -- 2.4.4. Effects -- 2.5. Palmitoyl tripeptide-1 -- 2.5.1. INCI name -- 2.5.2. Biological functions -- 2.5.3. Mechanism of action -- 2.5.4. Effects -- 3. Product application -- 3.1. Antihair loss serum -- 3.1.1. Formula -- 3.1.2. Processing -- 3.1.3. Core active ingredients -- References -- Chapter Nine: Antiwrinkle peptides -- 1. Overview -- 2. Introduction to antiwrinkle peptides -- 2.1. Acetyl hexapeptide-8 -- 2.1.1. INCI name -- 2.1.2. Biological functions -- 2.1.3. Mechanism of action -- 2.1.4. Effects -- 2.2. Dipeptide diaminobutyroyl benzylamide diacetate -- 2.2.1. INCI name -- 2.2.2. Biological functions -- 2.2.3. Mechanism of action -- 2.2.4. Effects -- 2.3. Acetyl octapeptide-3 -- 2.3.1. INCI name -- 2.3.2. Biological functions -- 2.3.3. Mechanism of action -- 2.3.4. Effects -- 2.4. Beta-alanyl hydroxyprolyldiaminobutyroyl benzylamide -- 2.4.1. INCI name -- 2.4.2. Biological functions -- 2.4.3. Mechanism of action -- 2.4.4. Effects -- 2.5. Conotoxin -- 2.5.1. INCI name -- 2.5.2. Biological functions -- 2.5.3. Mechanism of action -- 2.5.4. Effects -- 3. Product application -- 3.1. Formulation -- 3.1.1. Formulation case study -- 3.2. Processing -- 3.3. Core active ingredients -- References -- Chapter Ten: Breast enlargement and slimming peptides -- 1. Overview -- 2. Introduction to breast enlargement and slimming peptides -- 2.1. Acetyl hexapeptide-38 -- 2.1.1. INCI name -- 2.1.2. Biological functions -- 2.1.3. Mechanism of action -- 2.1.4. Effects -- 2.2. Acetyl hexapeptide-39. , 2.2.1. INCI name.
    Additional Edition: ISBN 9780443302879
    Additional Edition: ISBN 0443302871
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    San Diego :Elsevier Science & Technology,
    UID:
    edocfu_9961627035902883
    Format: 1 online resource (184 pages)
    Edition: 1st ed.
    ISBN: 9780443302886
    Note: Intro -- Active Peptides for Skin Care -- Copyright -- Contents -- Contributors -- Chapter One: Skin -- 1. Skin anatomy and physiology -- 1.1. Skin anatomy -- 1.1.1. Epidermis -- Stratum corneum -- Stratum lucidum -- Stratum granulosum -- Stratum spinosum -- Stratum basale -- Basement membrane -- 1.1.2. Dermis -- Dermal cells -- Hair fibers -- Sebaceous glands -- Sweat glands -- Blood vessels -- 1.1.3. Subcutaneous layer -- 1.2. Skin barrier -- 2. Aging skin -- 2.1. Internal factors -- 2.1.1. Genetics -- 2.1.2. Free oxygen radicals -- 2.1.3. Nonenzymatic glycosylation (NEG) -- 2.2. External factors -- 2.2.1. Exposure to sunlight -- 2.2.2. Environmental pollution -- 2.2.3. Unhealthy lifestyle -- 3. Skin care and beauty -- 3.1. Skincare -- 3.1.1. Healthy lifestyle -- 3.1.2. Emotion management -- 3.1.3. Skin hygiene -- 3.1.4. Prevention and precaution -- 3.2. Cosmetology -- 3.2.1. Esthetic injection -- 3.2.2. Chemexfoliation -- 3.2.3. Laser procedure -- 3.2.4. Skincare products -- References -- Chapter Two: Active peptides -- 1. The history and research of active peptides -- 2. Overview of peptides -- 2.1. The concept of ``peptides´´ -- 2.2. Difference among peptide, protein, and amino acid -- 3. Application of peptides -- 3.1. Pharmaceutical peptides -- 3.2. Cosmetic peptides -- 3.3. Food peptides -- 4. Types of peptides -- 5. Peptide synthesis -- 5.1. Chemical synthesis -- 5.1.1. Liquid-phase synthesis -- 5.1.2. Solid-phase peptide synthesis -- 5.2. Peptide purification -- 5.3. Genetic recombination of peptide synthesis -- 5.4. Protein hydrolysis -- 5.5. Acidolysis -- References -- Chapter Three: Transdermal therapeutic systems of peptides -- 1. Overview of transdermal therapeutic systems (TTS) -- 2. How transdermal therapeutic systems work -- 2.1. Routes of transdermal therapeutic systems -- 2.2. How transdermal therapeutic systems work. , 2.2.1. Transdermal diffusion process -- 2.2.2. The principle of osmotic pressure -- 2.2.3. Hydration theory -- 2.2.4. ``Like dissolves like´´ theory -- 2.2.5. Structural change theory -- 3. Transdermal drug delivery techniques -- 3.1. Physical approaches to transdermal drug delivery -- 3.1.1. Microporation -- 3.1.2. Iontophoresis -- 3.1.3. Electroporation -- 3.1.4. Sonophoresis -- 3.1.5. Laser technology -- 3.1.6. Spray-on transdermal spray-on systems -- 3.1.7. Other physical techniques -- 3.2. Pharmaceutical methods for transdermal drug delivery -- 3.2.1. Penetration enhancers -- 3.2.2. Liposomes -- 3.2.3. Nanoparticles -- 3.2.4. Microemulsion -- 3.2.5. Microencapsulation -- 4. Transdermal drug delivery of cosmetic peptides -- 4.1. Properties of cosmetic peptides -- 4.2. Research of transdermal absorption of cosmetic peptides -- 4.3. What are transdermal mediator peptides -- 4.4. Future transdermal drug delivery of cosmetic peptides -- References -- Chapter Four: Quality research of peptides -- 1. Analysis of peptide structure -- 1.1. Amino acid analysis -- 1.1.1. Postcolumn derivatization -- 1.1.2. Precolumn derivatization -- Phenyl isothiocyanate (PITC) derivatization -- O-Phthalaldehyde (OPA) derivatization -- 6-Aminoquinolinyl-N-hydroxysuccinimidyl carbamate (AQC) derivatization -- Dansyl chloride (Dansyl-Cl) derivatization -- 9-Fluorenylmethyl chloroformate (FMOC-Cl) derivatization -- 1.2. Sequence analysis -- 1.3. Mass spectrometry -- 1.3.1. Fast atom mass spectrometry (FAB-MS) -- 1.3.2. Electrospray ionization mass spectrometry (ESI-MS) -- 1.4. Peptide spectrum analysis -- 2. Purity analysis and content determination -- 2.1. Purity analysis of peptides -- 2.2. Content determination of peptides -- 3. Research on peptide impurities -- 3.1. Impurities from raw materials -- 3.2. Impurities from the process of synthesis. , 3.2.1. Isometric peptide impurities -- 3.2.2. Defective peptide impurities -- 3.2.3. Disjuncted peptide impurities -- 3.2.4. Protected peptide impurities -- 3.3. Degradation of impurities -- 3.3.1. Impurities from hydrolysis -- 3.3.2. Impurities from oxidation -- References -- Chapter Five: Whitening and spot-correcting peptides -- 1. Overview -- 2. Introduction of whitening and spot-correcting peptides -- 2.1. Nonapeptide-1 -- 2.1.1. INCI name -- 2.1.2. Biological functions -- 2.1.3. Mechanism of action -- 2.1.4. Effects -- 2.2. Glutathione -- 2.2.1. INCI name -- 2.2.2. Biological functions -- Scavenging free radicals -- Inhibiting lipid peroxidation of cell membranes -- Tyrosinase inhibition -- 2.2.3. Mechanism of action -- 2.2.4. Effects -- 2.3. Carnosine -- 2.3.1. INCI name -- 2.3.2. Biological functions -- Antioxidation and anti-ROS -- Antiaging -- Protein carbonylation inhibition -- 2.3.3. Mechanism of action -- 2.3.4. Effects -- 2.4. Hexapeptide-2 -- 2.4.1. INCI name -- 2.4.2. Mechanism of action -- 2.4.3. Effects -- 3. Whitening product application -- 3.1. Formulation -- 3.1.1. Formulation example -- 3.2. Processing -- 3.3. Whitening active ingredients -- 3.4. Whitening results -- References -- Chapter Six: Antiaging and repairing peptides -- 1. Overview -- 2. Antiaging pathways -- 3. Introduction of antiaging peptides -- 3.1. Carnosine -- 3.1.1. INCI name -- 3.1.2. Biological functions -- 3.1.3. Mechanism of action -- 3.1.4. Effects -- 3.2. Palmitoyl pentapeptide-4 -- 3.2.1. INCI name -- 3.2.2. Biological functions -- 3.2.3. Mechanism of action -- 3.2.4. Effects -- 3.3. Palmitoyl tripeptide-1 -- 3.3.1. INCI name -- 3.3.2. Biological functions -- 3.3.3. Mechanism of action -- 3.3.4. Effects -- 3.4. Palmitoyl tetrapeptide-7 -- 3.4.1. INCI name -- 3.4.2. Biological functions -- 3.4.3. Mechanism of action -- 3.4.4. Effects. , 3.5. Copper tripeptide-1 -- 3.5.1. INCI name -- 3.5.2. Biological functions and mechanism of action -- 3.5.3. Effects -- 3.6. Palmitoyl tripeptide-5 -- 3.6.1. INCI name -- 3.6.2. Biological functions -- 3.6.3. Mechanism of action -- 3.6.4. Effects -- 3.7. Palmitoyl hexapeptide-12 -- 3.7.1. INCI name -- 3.7.2. Biological functions [3] -- 3.7.3. Mechanism of action -- 3.7.4. Effects -- 3.8. Hexapeptide-9 -- 3.8.1. INCI name -- 3.8.2. Biological functions -- 3.8.3. Mechanism of action -- 3.8.4. Effects -- 3.9. Hexapeptide-11 -- 3.9.1. INCI name -- 3.9.2. Biological functions -- 3.9.3. Mechanism of action -- 3.9.4. Effects -- 4. Product application -- 4.1. Formulation -- 4.1.1. Product/formulation case study -- 4.2. Processing -- 4.3. Core active ingredients -- 4.4. Efficacy test -- References -- Chapter Seven: Antisensitive and soothing peptides -- 1. Overview -- 1.1. Sensitive skin -- 1.2. Causes of sensitive skin -- 1.2.1. Weakened skin barrier -- 1.2.2. Increased cutaneous nerve conduction -- 1.2.3. Inflammatory response -- 2. Introduction to antisensitive and soothing peptides -- 2.1. Palmitoyl tripeptide-8 -- 2.1.1. INCI name -- 2.1.2. Biological functions -- 2.1.3. Mechanism of action -- 2.1.4. Effects -- 2.2. Acetyl dipeptide-1 cetyl ester -- 2.2.1. INCI name -- 2.2.2. Biological function -- 2.2.3. Mechanism of action -- 2.2.4. Effects -- 2.3. Acetyl hexapeptide-95 amide -- 2.3.1. INCI name -- 2.3.2. Biological function -- 2.3.3. Mechanism of action -- 2.3.4. Effects -- 3. Product application -- 3.1. Product/formulation case study -- 3.1.1. Formulation -- 3.1.2. Processing -- 3.1.3. Core active ingredients -- References -- Chapter Eight: Antihair loss peptides -- 1. Overview -- 2. Introduction of antihair loss peptides -- 2.1. Biotinoyl tripeptide-1 -- 2.1.1. INCI name -- 2.1.2. Biological functions -- 2.1.3. Mechanism of action -- 2.1.4. Effects. , 2.2. Myristoyl pentapeptide-17 -- 2.2.1. INCI name -- 2.2.2. Biological functions -- 2.2.3. Mechanism of action -- 2.2.4. Effects -- 2.3. Acetyl tetrapeptide-3 -- 2.3.1. INCI name -- 2.3.2. Biological functions -- 2.3.3. Mechanism of action -- 2.3.4. Effects -- 2.4. Oligopeptide-1 -- 2.4.1. INCI name -- 2.4.2. Biological functions -- 2.4.3. Mechanism of action -- 2.4.4. Effects -- 2.5. Palmitoyl tripeptide-1 -- 2.5.1. INCI name -- 2.5.2. Biological functions -- 2.5.3. Mechanism of action -- 2.5.4. Effects -- 3. Product application -- 3.1. Antihair loss serum -- 3.1.1. Formula -- 3.1.2. Processing -- 3.1.3. Core active ingredients -- References -- Chapter Nine: Antiwrinkle peptides -- 1. Overview -- 2. Introduction to antiwrinkle peptides -- 2.1. Acetyl hexapeptide-8 -- 2.1.1. INCI name -- 2.1.2. Biological functions -- 2.1.3. Mechanism of action -- 2.1.4. Effects -- 2.2. Dipeptide diaminobutyroyl benzylamide diacetate -- 2.2.1. INCI name -- 2.2.2. Biological functions -- 2.2.3. Mechanism of action -- 2.2.4. Effects -- 2.3. Acetyl octapeptide-3 -- 2.3.1. INCI name -- 2.3.2. Biological functions -- 2.3.3. Mechanism of action -- 2.3.4. Effects -- 2.4. Beta-alanyl hydroxyprolyldiaminobutyroyl benzylamide -- 2.4.1. INCI name -- 2.4.2. Biological functions -- 2.4.3. Mechanism of action -- 2.4.4. Effects -- 2.5. Conotoxin -- 2.5.1. INCI name -- 2.5.2. Biological functions -- 2.5.3. Mechanism of action -- 2.5.4. Effects -- 3. Product application -- 3.1. Formulation -- 3.1.1. Formulation case study -- 3.2. Processing -- 3.3. Core active ingredients -- References -- Chapter Ten: Breast enlargement and slimming peptides -- 1. Overview -- 2. Introduction to breast enlargement and slimming peptides -- 2.1. Acetyl hexapeptide-38 -- 2.1.1. INCI name -- 2.1.2. Biological functions -- 2.1.3. Mechanism of action -- 2.1.4. Effects -- 2.2. Acetyl hexapeptide-39. , 2.2.1. INCI name.
    Additional Edition: ISBN 9780443302879
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Did you mean 0444002871?
Did you mean 0443300771?
Did you mean 0043302831?
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages